Teva Inks Patent Deal With Collegium Over Painkiller
Teva Pharmaceutical USA Inc. has inked a deal to resolve a patent case from Collegium Pharmaceutical Inc. over Teva's attempt to get a generic alternative to Collegium's Xtampza ER painkiller approved....To view the full article, register now.
Already a subscriber? Click here to view full article